On World Arthritis Day, we come together to raise awareness about arthritis and the millions of individuals impacted by this often-overlooked condition. Among those championing this cause is David Hyland, co-founder of INGENIOUS, whose personal journey sparked a commitment to collagen as a solution for joint health.
A Personal Motivation
David’s interest in collagen began over twenty years ago when he discovered a research paper from Harvard Medical School exploring collagen’s potential benefits for joint health. This discovery was particularly relevant to him as his wife, Sue, was showing early signs of arthritis. David’s first attempt at creating a supplement involved a simple bovine collagen powder encapsulated in gelatin. After both he and Sue took it, he noticed an improvement in her symptoms, igniting his passion for exploring the benefits of collagen.
Facing Scepticism
Despite early positive results, scepticism surrounded the effectiveness of oral collagen supplementation due to concerns that collagen is broken down into amino acids during digestion. David remained determined to find a viable solution, especially given that arthritis affects around 10 million people in the UK—about 1 in 6 adults. Many remain undiagnosed, struggling with overlooked or misdiagnosed symptoms. This can diminish self-esteem and increase dependence on welfare and healthcare systems, hindering their independence . However, amidst this scepticism, a key insight would soon emerge that would change everything for David.
The Lightbulb Moment
A breakthrough occurred when David realised that collagen’s effectiveness depended on its absorption in the small intestine,where 99% of nutrient absorption occurs. This insight led him to envision a protective capsule designed to bypass the stomach’s harsh digestive environment, preserving the collagen until it could be effectively absorbed. With this new understanding, David was ready to take the next step in his journey toward innovation.
A Partnership Built on Innovation
David’s vision truly came to life when he partnered with Pupinder Ghatora, a fellow pharmaceutical consultant and now co-founder of INGENIOUS. Their discussions around David’s theories on collagen led to a groundbreaking collaboration. Together, they patented a method to protect collagen, paving the way for the establishment of INGENIOUS. Their efforts concentrated on rigorous trials to develop a formula that effectively delivers collagen to the small intestine.
Collagen is vital for maintaining cartilage integrity, the tissue that cushions joints, while also helping to reduce inflammation and alleviate joint pain and stiffness. Unlike many products that rely on unprotected collagen and suggest excessive dosages, INGENIOUS Beauty contains just 637 mg of protected collagen, ensuring optimal absorption. Launched in 2016, it quickly gained acclaim, winning multiple awards, and its success was reinforced by a 2019 clinical trial that validated the effectiveness of its innovative formula.
Raising Awareness
Arthritis impacts around 10 million people in the UK, highlighting the need for effective solutions. David Hyland’s pioneering work with INGENIOUS underscores the significance of innovation in joint health. Collagen is crucial for maintaining cartilage and reducing inflammation, serving as a valuable ally for those with arthritis. If you know someone affected by this condition, share David’s journey and the advantages of collagen supplementation. By doing so, we can motivate others to explore innovative approaches that enhance their quality of life.